Internal Medicine, Endocrinology, Diabetes, & Metabolism · Jefferson City, MO
NPI
1871552794
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1241 W Stadium Blvd
Jefferson City, MO, 65109
Phone (573) 635-5264
Groups this clinician bills Medicare through
Medicare paid, 2024
$128K
5,540 services
Medicare patients, 2024
1,140
Average age 73
Drug cost, 2024
$5.1M
16,491 prescriptions
Company payments, 2025
$8,590
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher C Case was code 99213 (office e&m - established), 1,029 times for 536 patients. In total Christopher C Case billed 5,540 services in 58 codes, and Medicare paid $128K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-07-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,029 | 536 | $54.56 | $56K |
| 36415 Venipuncture Blood Collection | Office | 666 | 381 | $8.64 | $5,752 |
| 77092 Standard X-ray | Office | 506 | 506 | $5.74 | $2,903 |
| 80053 Clinical Chemistry | Office | 490 | 287 | $10.31 | $5,051 |
| 83036 Blood Count | Office | 484 | 252 | $9.49 | $4,593 |
| 84443 Clinical Chemistry | Office | 362 | 219 | $16.44 | $5,951 |
| 77085 Standard X-ray | Office | 338 | 338 | $13.16 | $4,447 |
| 84439 Clinical Chemistry | Office | 190 | 123 | $8.84 | $1,680 |
| 99214 Office E&M - Established | Office | 176 | 142 | $79.14 | $14K |
| 77080 Standard X-ray | Office | 174 | 174 | $8.77 | $1,526 |
| 80061 Clinical Chemistry | Office | 146 | 124 | $13.05 | $1,905 |
| 99203 Office E&M - New | Office | 94 | 94 | $64.94 | $6,105 |
| 82570 Clinical Chemistry | Office | 59 | 46 | $5.08 | $300 |
| 82043 Clinical Chemistry | Office | 58 | 46 | $5.66 | $328 |
| 84481 Clinical Chemistry | Office | 56 | 41 | $16.47 | $922 |
By year: 2022 $192K for 9,791 services; 2023 $144K for 6,079 services; 2024 $128K for 5,540 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 666 | 381 | $8.64 | $5,752 |
| 80053 Clinical Chemistry | 490 | 287 | $10.31 | $5,051 |
| 83036 Blood Count | 484 | 252 | $9.49 | $4,593 |
| 84443 Clinical Chemistry | 362 | 219 | $16.44 | $5,951 |
| 84439 Clinical Chemistry | 190 | 123 | $8.84 | $1,680 |
| 80061 Clinical Chemistry | 146 | 124 | $13.05 | $1,905 |
| 82570 Clinical Chemistry | 59 | 46 | $5.08 | $300 |
| 82043 Clinical Chemistry | 58 | 46 | $5.66 | $328 |
| 84481 Clinical Chemistry | 56 | 41 | $16.47 | $922 |
| 85025 Blood Count | 54 | 49 | $7.61 | $411 |
Medicare prescription drug claims, 2024
In 2024, the drug Christopher C Case prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,133 prescriptions and refills. In total Christopher C Case wrote 16,491 Medicare prescriptions that cost $5.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,133 | 2,713 | 267 | $12K |
| Glimepiride Generic | 963 | 2,523 | 265 | $11K |
| Metformin Hcl Generic | 743 | 1,866 | 184 | $7,149 |
| Ozempic Semaglutide | 724 | 1,262 | 176 | $1.2M |
| Pioglitazone Hcl Generic | 664 | 1,802 | 189 | $7,434 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 446 | 912 | 125 | $74K |
| Mounjaro Tirzepatide | 433 | 531 | 80 | $556K |
| Metformin Hcl Er Metformin Hcl | 428 | 1,085 | 116 | $4,026 |
| Tresiba Flextouch U-200 Insulin Degludec | 345 | 622 | 79 | $429K |
| Atorvastatin Calcium Generic | 335 | 875 | 92 | $3,477 |
| Humalog Kwikpen U-100 Insulin Lispro | 335 | 692 | 94 | $104K |
| Lisinopril Generic | 300 | 788 | 87 | $2,761 |
| Tresiba Flextouch U-100 Insulin Degludec | 290 | 569 | 77 | $184K |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 286 | 747 | 112 | $28K |
| Gabapentin Generic | 258 | 517 | 57 | $5,017 |
Brand drugs: 6,015 claims; generic drugs: 9,392 claims; opioid claims: 163.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher C Case $8,590 ($8,590 in general payments such as food, travel and fees) from 11 companies. The largest payer was Novo Nordisk Inc with $8,354.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 30 | $8,354 |
| Xeris Pharmaceuticals, Inc. | 3 | $53.4 |
| Corcept Therapeutics CORT | 2 | $37.31 |
| Pfizer Inc. PFE | 1 | $28.66 |
| Medtronic, Inc. MDT | 1 | $26.36 |
| Radius Health, Inc. | 1 | $19.02 |
| Abbott Laboratories ABT | 1 | $18.5 |
| Tolmar, Inc. | 1 | $18.29 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $18.05 |
| Amgen Inc. AMGN | 1 | $16.7 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.